Patents by Inventor Lowell L. Gibson

Lowell L. Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
    Patent number: 5972383
    Abstract: This invention provides orally administerable pharmaceutical formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, in combination with a hydrophilic carrier composition.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: October 26, 1999
    Assignee: Eli Lilly and Company
    Inventors: Lowell L. Gibson, Kerry J. Hartauer, Julian L. Stowers, Stephanie A. Sweetana, Arvind L. Thakkar
  • Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
    Patent number: 5811120
    Abstract: This invention provides solid orally administerable pharmaceutical formulations comprising raloxifene hydrochloride, a surfactant being sorbitan fatty acid ester or a polyoxyethylene sorbitan fatty acid ester, polyvinylpyrrolidone, and a water soluble diluent which is polyol or sugar.
    Type: Grant
    Filed: March 26, 1997
    Date of Patent: September 22, 1998
    Assignee: Eli Lilly and Company
    Inventors: Lowell L. Gibson, Kerry J. Hartauer, Julian L. Stowers, Stephanie A. Sweetana, Arvind L. Thakkar
  • Orally administerable sustained release pharmaceutical formulation
    Patent number: 5112619
    Abstract: This invention provides orally administerable pharmaceutical formulations having a semi-solid matrix containing a hydrophilic substance capable of creating channels in a hydrophobic carrier matrix thereby providing a sustained rate of release of an active agent from the formulation.
    Type: Grant
    Filed: September 14, 1989
    Date of Patent: May 12, 1992
    Assignee: Eli Lilly and Company
    Inventors: Arvind L. Thakkar, Lowell L. Gibson
  • Orally administerable sustained release pharmaceutical formulations
    Patent number: 4847092
    Abstract: This invention provides orally administerable pharmaceutical formulations having a semi-solid matrix containing a hydrophilic substance capable of creating channels in a hydrophobic carrier matrix thereby providing a sustained rate of release of an active agent from the formulation.
    Type: Grant
    Filed: August 19, 1988
    Date of Patent: July 11, 1989
    Assignee: Eli Lilly and Company
    Inventors: Arvind L. Thakkar, Lowell L. Gibson
  • Orally administerable sustained release pharmaceutical formulations
    Patent number: 4797286
    Abstract: This invention provides orally administerable pharmaceutical formulations having a semi-solid matrix containing a hydrophilic substance capable of creating channels in a hydrophobic carrier matrix thereby providing a sustained rate of release of an active agent from the formulation.
    Type: Grant
    Filed: November 12, 1985
    Date of Patent: January 10, 1989
    Assignee: Eli Lilly and Company
    Inventors: Arvind L. Thakkar, Lowell L. Gibson